CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05%
CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05%- tazarotene, niacinamide and clindamycin phosphate gel
Sincerus Florida, LLC
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Directions for use
Sincerus Florida, LLC. Adverse reactions
Active, inactive
NDC 72934-1050-2 CLINDAMYCIN PHOSPHATE USP 1% / NIACINAMIDE USP 2% / TAZAROTENE 0.05%. Gel 30gm
| CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05%
clindamycin 1% / niacinamide 2% / tazarotene 0.05% gel | |||||||||||||||
| |||||||||||||||
| |||||||||||||||
| |||||||||||||||
| |||||||||||||||
| Labeler — Sincerus Florida, LLC (080105003) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Sincerus Florida, LLC | 080105003 | manufacture (72934-1050) | |
Revised: 05/2019 Sincerus Florida, LLC
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.
https://medlibrary.org/lib/rx/meds/clindamycin-1-niacinamide-2-tazarotene-0-05/